Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments, and foundations. It manages separate client-focused equity, fixed income, multi-asset, and commodity portfolios through its subsidiaries. The firm launches and manages equity, fixed income, balanced, and multi-asset mutual funds through its subsidiaries. Through its subsidiaries, it also launches and manages hedge funds. The firm invests in public equity, fixed income, and commodity markets across the globe through its subsidiaries. Through its subsidiaries, it invests in companies operating in the real estate sector, including real estate investment trusts, infrastructure sector, and natural energy resources sector for its equity and fixed income investments. The firm also invests in preferred securities for its fixed income investments through its subsidiaries. Cohen & Steers, Inc. was founded in 1986 and is based in New York, with additional offices in London, United Kingdom; Central, Hong Kong; Tokyo, Japan; and Seattle, Washington.

Cohen & Steers, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

NEW YORK , NOV. 14, 2025 /PRNEWSWIRE/ -- COHEN & STEERS, INC. (NYSE: CNS) ANNOUNCED TODAY PENDING CHANGES TO ITS GLOBAL REALTY MAJORS PORTFOLIO INDEX (GRM) AND INTERNATIONAL REALTY MAJORS PORTFOLIO INDEX (IRP), EFFECTIVE AS OF THE CLOSE OF BUSINESS ON NOVEMBER 21, 2025. COHEN & STEERS GLOBAL REALTY MAJORS PORTFOLIO INDEX (GRM) ADDED COMPONENT (SYMBOL)        REMOVED COMPONENT (SYMBOL) SWISS PRIME SITE AG (SPSN.SW) COVIVIO SA (COV.FP) COHEN & STEERS INTERNATIONAL REALTY MAJORS PORTFOLIO INDEX (IRP) ADDED COMPONENT (SYMBOL)        REMOVED COMPONENT (SYMBOL) SWISS PRIME SITE AG (SPSN.SW) COVIVIO SA (COV.FP) THESE FREE-FLOAT ADJUSTED, MODIFIED MARKET CAPITALIZATION-WEIGHTED TOTAL RETURN INDEXES OF SELECTED REAL ESTATE EQUITY SECURITIES ARE QUOTED INTRADAY ON A REAL-TIME BASIS BY THE CHICAGO MERCANTILE EXCHANGE.

COHEN & STEERS ANNOUNCES CHANGES TO REALTY INDEXES

NEW YORK , NOV. 13, 2025 /PRNEWSWIRE/ -- COHEN & STEERS, INC. (NYSE:CNS) ANNOUNCED TODAY THAT DANIEL NOONAN, EXECUTIVE VICE PRESIDENT AND HEAD OF GLOBAL WEALTH, HAS BEEN PROMOTED TO HEAD OF GLOBAL DISTRIBUTION. MR. NOONAN WILL LEAD ALL ASPECTS OF THE COMPANY'S BUSINESS DEVELOPMENT, CLIENT SERVICE AND MARKETING EFFORTS, PROVIDING STRATEGIC DIRECTION FOR BOTH INSTITUTIONAL AND WEALTH MARKETS GLOBALLY.

COHEN & STEERS PROMOTES DANIEL NOONAN TO HEAD OF GLOBAL DISTRIBUTION

NEW YORK , NOV. 10, 2025 /PRNEWSWIRE/ -- COHEN & STEERS, INC. (NYSE: CNS) TODAY REPORTED PRELIMINARY ASSETS UNDER MANAGEMENT OF $90.6 BILLION AS OF OCTOBER 31, 2025, A DECREASE OF $312 MILLION FROM ASSETS UNDER MANAGEMENT OF $90.9 BILLION AT SEPTEMBER 30, 2025. THE DECREASE WAS DUE TO MARKET DEPRECIATION OF $1.3 BILLION AND DISTRIBUTIONS OF $150 MILLION, PARTIALLY OFFSET BY NET INFLOWS OF $1.1 BILLION.

COHEN & STEERS ANNOUNCES PRELIMINARY ASSETS UNDER MANAGEMENT AND NET FLOWS FOR OCTOBER 2025

VANCOUVER, BRITISH COLUMBIA, NOV. 10, 2025 (GLOBE NEWSWIRE) -- RAKOVINA THERAPEUTICS INC. (RAKOVINA OR THE COMPANY) (TSX-V: RKV)(FSE: 7JO0) A BIOPHARMACEUTICAL COMPANY ADVANCING CANCER THERAPIES THROUGH AI-ENABLED DRUG DISCOVERY, TODAY ANNOUNCED THAT NEW DATA WILL BE PRESENTED IN TWO POSTERS AT THE SOCIETY FOR NEURO-ONCOLOGY (SNO) ANNUAL MEETING, TAKING PLACE NOVEMBER 1923, 2025, IN HONOLULU, HAWAII. THE PRESENTATIONS WILL HIGHLIGHT RAKOVINA'S AI-DRIVEN PROGRAMS TO DISCOVER AND DEVELOP NEXT-GENERATION DNA-DAMAGE RESPONSE (DDR) INHIBITORS ENGINEERED FOR CENTRAL NERVOUS SYSTEM (CNS) PENETRATION, SUPPORTING THE DEVELOPMENT OF POTENTIAL NEW TREATMENT OPTIONS FOR PRIMARY AND METASTATIC BRAIN CANCERS. PRESENTATION DETAILS:

RAKOVINA THERAPEUTICS TO PRESENT NEW DATA HIGHLIGHTING CNS-PENETRANT ATR AND PARP1 INHIBITORS AT THE 2025 SOCIETY FOR NEURO-ONCOLOGY ANNUAL MEETING

HOUSTON, TX / ACCESS NEWSWIRE / NOVEMBER 10, 2025 / CNS PHARMACEUTICALS, INC. (NASDAQ:CNSP) ("CNS" OR THE "COMPANY"), A BIOPHARMACEUTICAL COMPANY SPECIALIZING IN THE DEVELOPMENT OF NOVEL TREATMENTS FOR PRIMARY AND METASTATIC CANCERS IN THE BRAIN AND CENTRAL NERVOUS SYSTEM, TODAY ANNOUNCED THAT THREE ABSTRACTS HAVE BEEN SELECTED FOR POSTER PRESENTATION AT THE 2025 SNO ANNUAL MEETING BEING HELD NOVEMBER 19-23, 2025 IN HONOLULU, HI. DETAILS OF THE POSTER PRESENTATIONS ARE AS FOLLOWS: TITLE: ACTIVITY OF BERUBICIN AGAINST PEDIATRIC DIFFUSE MIDLINE GLIOMA (DMG) CELLS: PRELIMINARY DATA AND FUTURE POSSIBILITIES PRESENTER: SANDRA SILBERMAN, MD, PHD, CHIEF MEDICAL OFFICER OF CNS PHARMACEUTICALS ABSTRACT CODE: EXTH-133 DATE AND TIME: FRIDAY, NOVEMBER 21, 2025 AT 11:45 AM - 1:05 PM HST LOCATION: HAWAII CONVENTION CENTER, KAMEHAMEHA EXHIBIT HALL II & III TITLE: TPI 287, WHICH IN COMBINATION WITH BEVACIZUMAB (BEV) HAS SHOWN ACTIVITY IN PATIENTS WITH GLIOBLASTOMA (GBM) AFTER PRIOR THERAPY, WILL BE EVALUATED IN A PHASE 2 TRIAL AS WELL AS IN OTHER CNS DISEASES PRESENTER: SANDRA SILBERMAN, MD, PHD, CHIEF MEDICAL OFFICER OF CNS PHARMACEUTICALS ABSTRACT CODE: CTNI-70 DATE AND TIME: SATURDAY, NOVEMBER 22, 2025 AT 11:45 AM - 1:05 PM HST LOCATION: HAWAII CONVENTION CENTER, KAMEHAMEHA EXHIBIT HALL II & III TITLE: PRIMARY RESULTS OF THE RANDOMIZED CLINICAL TRIAL OF BERUBICIN VS LOMUSTINE IN PATIENTS WITH GLIOBLASTOMA AFTER FAILURE OF PRIMARY THERAPY: DATA ANALYSIS AND FUTURE POSSIBILITIES PRESENTER: SANDRA SILBERMAN, MD, PHD, CHIEF MEDICAL OFFICER OF CNS PHARMACEUTICALS ABSTRACT CODE: CTNI-74 DATE AND TIME: SATURDAY, NOVEMBER 22, 2025 AT 11:30 AM - 12:45 PM HST LOCATION: HAWAII CONVENTION CENTER, KAMEHAMEHA EXHIBIT HALL II & III FOR MORE INFORMATION ABOUT THE EVENT, PLEASE VISIT THE MEETING WEBSITE.

CNS PHARMACEUTICALS ANNOUNCES ACCEPTANCE OF THREE ABSTRACTS FOR POSTER PRESENTATION AT THE SOCIETY OF NUEROONCOLOGY (SNO) 30TH ANNUAL MEETING

MAJOR CUSTOMER RENEWAL, GLOBAL EXPANSION, AND NEW INNOVATIONS POSITION CORERO FOR CONTINUED GROWTH INTO 2026 LONDON , NOV. 5, 2025 /PRNEWSWIRE/ -- CORERO NETWORK SECURITY (AIM: CNS) (OTCQX: DDOSF), A RECOGNIZED LEADER IN DDOS PROTECTION AND CHAMPION OF ADAPTIVE, REAL-TIME SERVICE AVAILABILITY, TODAY REPORTED ACCELERATING GLOBAL GROWTH IN Q3 2025, FUELED BY RISING ORDER INTAKE AND CONTINUED INNOVATION ACROSS ITS SMARTWALL ONE PLATFORM, AND BEGAN Q4 WITH A MAJOR RENEWAL AND EXPANSION WITH A LEADING US CLOUD COMPUTING PROVIDER. BUILDING ON STRONG EXECUTION, CORERO ACHIEVED $7.4 MILLION IN Q3 ORDER INTAKE (UP FROM $6.0 MILLION IN Q3 2024) WITH NEW CUSTOMER WINS SPANNING THE US, UK, EUROPE, BRAZIL, AND SINGAPORE.

CORERO NETWORK SECURITY BUILDS ON Q3 EXECUTION WITH MAJOR Q4 WINS AND PRODUCT BREAKTHROUGHS

NEW YORK , OCT. 30, 2025 /PRNEWSWIRE/ -- THE BOARD OF DIRECTORS OF COHEN & STEERS, INC. (NYSE: CNS) DECLARED A CASH DIVIDEND FOR THE FOURTH QUARTER OF 2025 IN THE AMOUNT OF $0.62 PER SHARE OF COMMON STOCK PAYABLE ON NOVEMBER 20, 2025, TO STOCKHOLDERS OF RECORD AS OF THE CLOSE OF BUSINESS ON NOVEMBER 10, 2025. ABOUT COHEN & STEERS.

COHEN & STEERS, INC. DECLARES QUARTERLY DIVIDEND

NEW YORK , OCT. 28, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS CLOSED-END OPPORTUNITY FUND, INC. (NYSE: FOF) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON OCTOBER 31, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE. IN DECEMBER 2021, THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITH EXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION.

COHEN & STEERS CLOSED-END OPPORTUNITY FUND, INC. (FOF) NOTIFICATION OF SOURCES OF DISTRIBUTION UNDER SECTION 19(A)

NEW YORK , OCT. 28, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS INFRASTRUCTURE FUND, INC. (NYSE: UTF) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON OCTOBER 31, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE. IN MARCH 2015, THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITH EXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION.

COHEN & STEERS INFRASTRUCTURE FUND, INC. (UTF) NOTIFICATION OF SOURCES OF DISTRIBUTION UNDER SECTION 19(A)

NEW YORK , OCT. 28, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERSREIT AND PREFERRED AND INCOME FUND, INC. (NYSE: RNP) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON OCTOBER 31, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE IN DECEMBER 2017, THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITH EXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION. THE MANAGED DISTRIBUTION POLICY SEEKS TO DELIVER THE FUND'S LONG-TERM TOTAL RETURN POTENTIAL THROUGH REGULAR MONTHLY DISTRIBUTIONS DECLARED AT A FIXED RATE PER COMMON SHARE.

COHEN & STEERS REIT AND PREFERRED AND INCOME FUND, INC. (RNP) NOTIFICATION OF SOURCES OF DISTRIBUTION UNDER SECTION 19(A)

NEW YORK , OCT. 28, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS QUALITY INCOME REALTY FUND, INC. (NYSE:RQI) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON OCTOBER 31, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE. IN DECEMBER 2012, THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITHEXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION.

COHEN & STEERS QUALITY INCOME REALTY FUND, INC. (RQI) NOTIFICATION OF SOURCES OF DISTRIBUTION UNDER SECTION 19(A)

NEW YORK , OCT. 28, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS TOTAL RETURN REALTY FUND, INC. (NYSE: RFI) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON OCTOBER 31, 2025AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE. IN DECEMBER 2011, THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITH EXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION.

COHEN & STEERS TOTAL RETURN REALTY FUND, INC. (RFI) NOTIFICATION OF SOURCES OF DISTRIBUTION UNDER SECTION 19(A)

CUPERTINO, CALIF., OCT. 28, 2025 (GLOBE NEWSWIRE) -- REVIVA PHARMACEUTICALS HOLDINGS, INC. (NASDAQ: RVPH) (REVIVA OR THE COMPANY), A LATE-STAGE PHARMACEUTICAL COMPANY DEVELOPING THERAPIES THAT SEEK TO ADDRESS UNMET MEDICAL NEEDS IN THE AREAS OF CENTRAL NERVOUS SYSTEM (CNS), INFLAMMATORY AND CARDIOMETABOLIC DISEASES, TODAY ANNOUNCED THAT NEGATIVE SYMPTOM DATA FOR BRILAROXAZINE FROM THE PHASE 3 RECOVER DOUBLE-BLIND TRIAL IN PATIENTS WITH ACUTE EXACERBATION OF SCHIZOPHRENIA, AND FROM THE LONG-TERM OPEN-LABEL EXTENSION TRIAL IN CLINICALLY STABLE SCHIZOPHRENIA PATIENTS WILL BE PRESENTED AS A POSTER PRESENTATION AT THE CNS SUMMIT 2025, TAKING PLACE NOVEMBER 2-5, IN BOSTON, MASSACHUSETTS.

REVIVA TO PRESENT NEGATIVE SYMPTOM DATA FOR BRILAROXAZINE IN SCHIZOPHRENIA FROM THE PHASE 3 RECOVER DOUBLE-BLIND AND OPEN-LABEL EXTENSION TRIALS AT THE CNS SUMMIT 2025

NEW SMARTWALL ONE CAPABILITY STOPS HIDDEN L7 TLS ATTACKS IN REAL TIME WITHOUT LATENCY, DECRYPTION, OR ADDED INFRASTRUCTURE LONDON , OCT. 28, 2025 /PRNEWSWIRE/ -- CORERO NETWORK SECURITY (AIM: CNS) (OTCQX: DDOSF), A RECOGNIZED LEADER IN DDOS PROTECTION AND CHAMPION OF ADAPTIVE, REAL-TIME SERVICE AVAILABILITY, TODAY ANNOUNCED A NEW SMARTWALL ONE CAPABILITY THAT STOPS ENCRYPTED APPLICATION-LAYER ATTACKS IN REAL TIME WITHOUT ADDED LATENCY OR INFRASTRUCTURE. THE ENHANCEMENT ADDRESSES ONE OF THE MOST PRESSING BLIND SPOTS IN MODERN CYBERSECURITY.

CORERO NETWORK SECURITY SOLVES ENCRYPTED DDOS BLIND SPOT FOR SERVICE PROVIDERS AND ENTERPRISES

NEW YORK , OCT. 21, 2025 /PRNEWSWIRE/ -- THE BOARD OF DIRECTORS OF THE COHEN & STEERS INFRASTRUCTURE FUND, INC. (THE "FUND") ANNOUNCED TODAY THE MONTHLY DISTRIBUTIONS FOR NOVEMBER AND DECEMBER 2025, AS SUMMARIZED IN THE CHARTS BELOW: TICKER FUND NAME MONTHLY DIVIDEND UTF COHEN & STEERS INFRASTRUCTURE FUND, INC. $0.155 THE DISTRIBUTIONS WILL BE MADE ON THE FOLLOWING SCHEDULE: MONTH EX-DIVIDEND/ RECORD DATE PAYABLE DATE NOVEMBER NOV. 12, 2025 NOV. 28, 2025 DECEMBER DEC. 09, 2025 DEC. 31, 2025 THE FUND DECLARED ITS MONTHLY DISTRIBUTIONS PURSUANT TO THE FUND'S MANAGED DISTRIBUTION PLAN. THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITH EXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION.

COHEN & STEERS INFRASTRUCTURE FUND, INC. DECLARES DISTRIBUTIONS FOR NOVEMBER AND DECEMBER 2025

NEW YORK , OCT. 17, 2025 /PRNEWSWIRE/ -- COHEN & STEERS INFRASTRUCTURE FUND, INC. (NYSE: UTF) (THE "FUND") TODAY ANNOUNCED THE RESULTS OF ITS TRANSFERABLE RIGHTS OFFERING (THE "OFFER"), WHICH COMMENCED ON SEPTEMBER 22, 2025 AND EXPIRED ON OCTOBER 16, 2025 (THE "EXPIRATION DATE"). THE OFFERING WAS LED BY UBS INVESTMENT BANK AS THE SOLE DEALER MANAGER.

COHEN & STEERS INFRASTRUCTURE FUND, INC. ANNOUNCES PRELIMINARY RESULTS OF TRANSFERABLE RIGHTS OFFERING

NEW YORK , OCT. 16, 2025 /PRNEWSWIRE/ -- COHEN & STEERS, INC. (NYSE:CNS) TODAY REPORTED ITS RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025. THE EARNINGS RELEASE ALONG WITH THE ACCOMPANYING EARNINGS PRESENTATION CAN BE VIEWED AT COHEN & STEERS REPORTS RESULTS FOR THIRD QUARTER 2025 AND ON THE COMPANY'S WEBSITE AT WWW.COHENANDSTEERS.COMUNDER "COMPANYINVESTOR RELATIONSEARNINGS ARCHIVE.

COHEN & STEERS REPORTS RESULTS FOR THIRD QUARTER 2025

 AN ANALYSIS DESIGNED TO EVALUATE THE POTENTIAL EFFECTS OF THE PHASE 3 ZOREVUNERSEN DOSING REGIMEN SHOWED CONTINUING IMPROVEMENTS IN COGNITION AND BEHAVIOR AT 2 YEARS; RESULTS CONTRAST WITH MINIMAL CHANGE IN NATURAL HISTORY 

BIOGEN AND STOKE THERAPEUTICS PRESENT NEW DATA AT THE 54TH CHILD NEUROLOGY SOCIETY (CNS) ANNUAL MEETING THAT SUPPORT THE POTENTIAL OF ZOREVUNERSEN AS A DISEASE-MODIFYING MEDICINE FOR DRAVET SYNDROME

BEDFORD, MASS., & CAMBRIDGE, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK), A BIOTECHNOLOGY COMPANY DEDICATED TO RESTORING PROTEIN EXPRESSION BY HARNESSING THE BODY'S POTENTIAL WITH RNA MEDICINE, AND BIOGEN INC. (NASDAQ: BIIB) TODAY ANNOUNCED THE PRESENTATION OF LONGER-TERM FOLLOW-UP ANALYSES FROM THE ONGOING OPEN-LABEL EXTENSION (OLE) STUDIES OF ZOREVUNERSEN THAT SUPPORT THE POTENTIAL OF ZOREVUNERSEN AS A DISEASE-MODIFYING MEDICINE FOR DRAVET SYNDROME. THESE NEW RESULTS WERE.

STOKE THERAPEUTICS AND BIOGEN PRESENT NEW DATA AT THE 54TH CHILD NEUROLOGY SOCIETY (CNS) ANNUAL MEETING THAT SUPPORT THE POTENTIAL OF ZOREVUNERSEN AS A DISEASE-MODIFYING MEDICINE FOR DRAVET SYNDROME

NEW YORK , OCT. 8, 2025 /PRNEWSWIRE/ -- COHEN & STEERS, INC. (NYSE: CNS) ANNOUNCED THAT IT EXPECTS TO RELEASE THIRD QUARTER 2025 RESULTS AFTER THE MARKET CLOSES ON THURSDAY, OCTOBER 16, 2025. THE EARNINGS RELEASE AND ACCOMPANYING EARNINGS PRESENTATION WILL BE AVAILABLE ON THE COMPANY'S WEBSITE AT WWW.COHENANDSTEERS.COMUNDER "COMPANYINVESTOR RELATIONSEARNINGS ARCHIVE.

COHEN & STEERS, INC. TO RELEASE THIRD QUARTER 2025 RESULTS ON OCTOBER 16, 2025

NEW YORK , OCT. 8, 2025 /PRNEWSWIRE/ -- COHEN & STEERS, INC. (NYSE:CNS) TODAY REPORTED PRELIMINARY ASSETS UNDER MANAGEMENT OF $90.9 BILLION AS OF SEPTEMBER 30, 2025, AN INCREASE OF $542 MILLION FROM ASSETS UNDER MANAGEMENT OF $90.4 BILLION AT AUGUST 31, 2025. THE INCREASE WAS DUE TO MARKET APPRECIATION OF $945 MILLION, PARTIALLY OFFSET BY DISTRIBUTIONS OF $322 MILLION AND NET OUTFLOWS OF $81 MILLION.

COHEN & STEERS ANNOUNCES PRELIMINARY ASSETS UNDER MANAGEMENT AND NET FLOWS FOR SEPTEMBER 2025

FEATURING DUREPAIR DURA REGENERATION MATRIX AND MAYFIELD GHOST BASE UNIT, POST FEATURING DUREPAIR DURA REGENERATION MATRIX AND MAYFIELD GHOST BASE UNIT, POST

INTEGRA LIFESCIENCES TO SPOTLIGHT NEUROSURGICAL PRODUCT PORTFOLIO AT THE CONGRESS OF NEUROLOGICAL SURGEONS (CNS) ANNUAL MEETING

SOLANA BEACH, CALIFORNIA / ACCESS NEWSWIRE / OCTOBER 7, 2025 / CLEARPOINT NEURO, INC. (NASDAQ:CLPT) (THE "COMPANY"), A GLOBAL DEVICE, CELL, AND GENE THERAPY-ENABLING COMPANY OFFERING PRECISE NAVIGATION TO THE BRAIN AND SPINE, TODAY ANNOUNCED RESULTS FROM A PHASE I-II CLINICAL STUDY AT SKNE UNIVERSITY HOSPITAL IN LUND, SWEDEN EVALUATING THE CLEARPOINT PRISM NEURO LASER THERAPY SYSTEM'S SAFETY, FEASIBILITY, AND EFFICACY. THE STUDY COHORT COMPRISED FOURTEEN PATIENTS AGES 18-80YEARS WITH PRIMARY AND RECURRENT GLIOBLASTOMA AND GRADE 4 ASTROCYTOMA, TUMORS WHICH ARE AMONG THE MOST CHALLENGING TO TREAT.

CLEARPOINT NEURO ANNOUNCES PROMISING RESULTS FROM BRAIN TUMOR LASER THERAPY STUDY TO BE PRESENTED AT THE CNS ANNUAL MEETING IN LOS ANGELES

NEW YORK , SEPT. 29, 2025 /PRNEWSWIRE/ --THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS CLOSED-END OPPORTUNITY FUND, INC. (NYSE: FOF) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON SEPTEMBER 30, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE.

NEW YORK , SEPT. 29, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS TOTAL RETURN REALTY FUND, INC. (NYSE: RFI) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON SEPTEMBER 30, 2025AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE.

NEW YORK , SEPT. 29, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS REIT AND PREFERRED AND INCOME FUND, INC. (NYSE: RNP) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON SEPTEMBER 30, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE.

NEW YORK , SEPT. 29, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS QUALITY INCOME REALTY FUND, INC. (NYSE: RQI) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON SEPTEMBER 30, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE.

NEW YORK , SEPT. 29, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS INFRASTRUCTURE FUND, INC. (NYSE: UTF) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON SEPTEMBER 30, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE.

HOUSTON, SEPT. 25, 2025 (GLOBE NEWSWIRE) -- CNSIDE DIAGNOSTICS, LLC, A WHOLLY-OWNED SUBSIDIARY OFPLUS THERAPEUTICS, INC.(NASDAQ:PSTV) (PLUS OR THE COMPANY), ANNOUNCED TODAY THAT IT HAS SIGNED A NATIONAL AGREEMENT WITH UNITEDHEALTHCARE INSURANCE COMPANY (NYSE: UNH), EFFECTIVESEPTEMBER 15, 2025, COVERING OVER 51 MILLION PEOPLE THROUGHOUTTHE UNITED STATES, TO PROVIDE THE CNSIDE CEREBROSPINAL FLUID TUMOR CELL ENUMERATION LABORATORY DEVELOPED TEST (LDT).

PLUS THERAPEUTICS ANNOUNCES NATIONAL COVERAGE AGREEMENT WITH UNITEDHEALTHCARE INSURANCE COMPANY FOR CNSIDE CEREBROSPINAL FLUID ASSAY FOR METASTATIC CNS CANCER

LONDON , SEPT. 25, 2025 /PRNEWSWIRE/ -- TODAY, CORERO NETWORK SECURITY (AIM: CNS) (OTCQX: DDOSF), A RECOGNIZED LEADER IN DDOS PROTECTION AND CHAMPION OF ADAPTIVE, REAL-TIME SERVICE AVAILABILITY, ANNOUNCED ITS STRATEGIC PARTNERSHIP WITH ONESECURE ASIA PTE LTD, MARKING CORERO'S OFFICIAL ENTRY INTO THE SINGAPORE MARKET AND AN EXPANDED PRESENCE ACROSS SOUTHEAST ASIA.

CORERO NETWORK SECURITY ENTERS SINGAPORE MARKET THROUGH PARTNERSHIP WITH ONESECURE ASIA

NEW AGREEMENT BRINGS ADVANCED DDOS PROTECTION, TRAFFIC ANALYSIS, AND ZERO TRUST CONTROLS TO UK SERVICE PROVIDERS LONDON , SEPT. 24, 2025 /PRNEWSWIRE/ -- TODAY, CORERO NETWORK SECURITY (AIM: CNS) (OTCQX: DDOSF), A RECOGNIZED LEADER IN DDOS PROTECTION AND CHAMPION OF ADAPTIVE, REAL-TIME SERVICE AVAILABILITY, ANNOUNCED THE EXPANSION OF ITS STRATEGIC PARTNERSHIP WITH NETCEED INTO THE UNITED KINGDOM.

CORERO NETWORK SECURITY EXPANDS PARTNERSHIP WITH NETCEED TO STRENGTHEN UK NETWORK RESILIENCE

NEW YORK , SEPT. 23, 2025 /PRNEWSWIRE/ -- THE BOARD OF DIRECTORS OF THE COHEN & STEERS CLOSED-END FUNDS ANNOUNCED TODAY THE MONTHLY DISTRIBUTIONS FOR OCTOBER, NOVEMBER AND DECEMBER 2025, AS SUMMARIZED IN THE CHARTS BELOW: TICKER FUND NAME MONTHLYDIVIDEND FOF COHEN & STEERS CLOSED-END OPPORTUNITY FUND, INC. $0.087 LDP COHEN & STEERS LIMITED DURATION PREFERRED AND INCOME FUND, INC. $0.131 PSF COHEN & STEERS SELECT PREFERRED AND INCOME FUND, INC. $0.126 PTA COHEN & STEERS TAX-ADVANTAGED PREFERRED SECURITIES AND INCOME FUND $0.134 RFI COHEN & STEERS TOTAL RETURN REALTY FUND, INC. $0.080 RLTY COHEN & STEERS REAL ESTATE OPPORTUNITIES AND INCOME FUND $0.110 RNP COHEN & STEERS REIT AND PREFERRED AND INCOME FUND, INC. $0.136 RQI COHEN & STEERS QUALITY INCOME REALTY FUND, INC. $0.080 DISTRIBUTIONS WILL BE MADE ON THE FOLLOWING SCHEDULE: MONTH EX-DIVIDEND/ RECORD DATE PAYABLE DATE OCTOBER OCT. 14, 2025 OCT. 31, 2025 NOVEMBER NOV. 12, 2025 NOV. 28, 2025 DECEMBER DEC. 9, 2025 DEC. 31, 2025 COHEN & STEERS TAX-ADVANTAGED PREFERRED SECURITIES AND INCOME FUND, COHEN & STEERS REAL ESTATE OPPORTUNITIES AND INCOME FUND, COHEN & STEERS LIMITED DURATION PREFERRED AND INCOME FUND, INC., AND COHEN & STEERS SELECT PREFERRED AND INCOME FUND, INC. PAY REGULAR MONTHLY CASH DISTRIBUTIONS TO COMMON SHAREHOLDERS AT A LEVEL RATE THAT MAY BE ADJUSTED FROM TIME TO TIME.

COHEN & STEERS CLOSED-END FUNDS DECLARE DISTRIBUTIONS FOR OCTOBER, NOVEMBER AND DECEMBER 2025

LONDON , SEPT. 23, 2025 /PRNEWSWIRE/ -- TODAY, CORERO NETWORK SECURITY (AIM: CNS) (OTCQX: DDOSF), A RECOGNIZED LEADER IN DDOS PROTECTION AND CHAMPION OF ADAPTIVE, REAL-TIME SERVICE AVAILABILITY, ANNOUNCED A NEW STRATEGIC PARTNERSHIP WITH ATLANTIC DATA SECURITY (ADS), EXPANDING CORERO'S PARTNER ECOSYSTEM AND U.S. MARKET PRESENCE TO HELP ENTERPRISES SAFEGUARD UPTIME, REDUCE CYBER RISK, AND ENSURE CONTINUOUS OPERATIONS THROUGH REAL-TIME DDOS PROTECTION.

CORERO NETWORK SECURITY AND ATLANTIC DATA SECURITY FORM STRATEGIC BUSINESS RESILIENCY PARTNERSHIP

NEW YORK , SEPT. 18, 2025 /PRNEWSWIRE/ -- COHEN & STEERS (NYSE:CNS) ANNOUNCED TODAY THAT FUNDS MANAGED BY THE PRIVATE REAL ESTATE GROUP OF COHEN & STEERS AND LINCOLN PROPERTY COMPANY HAVE ENTERED INTO A JOINT VENTURE TO OWN CITYLINE AT TENLEY, A RETAIL CENTER IN TENLEYTOWN, AN AFFLUENT NEIGHBORHOOD IN NORTHWEST WASHINGTON D.C.

COHEN & STEERS AND LINCOLN PROPERTY COMPANY FORM JOINT VENTURE ON CITYLINE AT TENLEY RETAIL CENTER IN WASHINGTON, D.C.

MIPLYFFA, THE ONLY THERAPY FOR NIEMANN-PICK DISEASE TYPE C (NPC) SHOWN TO STOP DISEASE PROGRESSION AT 12 MONTHS, HAS BEEN ADMINISTERED TO MORE THAN 270 PATIENTS, REPRESENTING THE LARGEST DATA SET OF NPC CLINICAL TRIAL PATIENTS

ZEVRA THERAPEUTICS ANNOUNCES UPCOMING ORAL PRESENTATION AT THE INTERNATIONAL NIEMANN-PICK DISEASE ALLIANCE (INPDA) MEETING AND POSTER PRESENTATIONS AT THE CHILD NEUROLOGY SOCIETY (CNS) CONFERENCE ON MIPLYFFA (ARIMOCLOMOL) AND OLPRUVA (SODIUM PHENYLBUTYRATE)

Cohen & Steers, Inc.

CNS

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Cohen & Steers, Inc.

CNS.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

CNS